Key result
Roux-en-Y gastric bypass linked to a ~21% CRP reduction alongside improved cardiometabolic profiles.
Why the study?
Changes over time in inflammatory and cardiometabolic profiles after Roux-en-Y gastric bypass in overweight Chinese patients were not well characterized.
Does Roux-en-Y gastric bypass improve inflammatory and cardiometabolic profiles in overweight Chinese patients?
Cohort (n=89)
No
Does Roux-en-Y gastric bypass improve inflammatory and cardiometabolic profiles in overweight Chinese patients?
Absolute Event Rate: 31.06% vs 39.39%
p-value: p=< 0.001
Roux-en-Y gastric bypass is associated with significant improvements in inflammatory markers and cardiometabolic profiles over 12 months in an overweight Chinese cohort.
May support cardiometabolic benefits of RYGB in overweight Chinese adults; leaves open randomized confirmation and event reduction.
Objective: To report on the changes over time in inflammatory and cardiometabolic profile after Roux-en-Y gastric bypass in an overweight Chinese cohort. Setting: Outpatient clinic of a hospital in Beijing, China. Methods: This prospective cohort study involved 89 patients who met the indications for bariatric surgery in China. Serum leptin, tumor necrosis factor α (TNF-α), adiponectin, C-reactive protein (CRP), interleukin-6 (IL-6), and cardiometabolic profile were monitored at baseline (presurgery) to 12 months postsurgery. Results: Serum CRP decreased from 39.39 mg/dL at baseline to 31.06 mg/dL at 12 months (p < 0.001). Serum leptin and IL-6 also steadily decreased throughout this time course, whereas serum adiponectin decreased to 5.52 μg/mL at 6 months and increased thereafter. An inconsistent pattern was observed for TNF-α. Fasted lipid profile, blood glucose, and HbA1c improved during follow-up. Conclusion: Weight loss after bariatric surgery was associated with lower serum concentrations of several inflammatory markers and an improved cardiometabolic profile during the first 12 months of follow-up in this Chinese cohort. These findings may reflect improvement in subclinical inflammation secondary to the reduction of the body fat mass, but also suggest other potential mechanisms to explain the improvement of cardiometabolic profile after metabolic surgery.
No takes yet. Share an insight, caveat, or question.
Mazidi et al. (2017) conducted a cohort in Overweight (n=89). Roux-en-Y gastric bypass vs. Baseline (presurgery) was evaluated on Serum CRP (mg/dL) (p=< 0.001). Roux-en-Y gastric bypass was associated with a significant decrease in serum CRP from 39.39 mg/dL at baseline to 31.06 mg/dL at 12 months (p < 0.001), alongside improved cardiometabolic profiles.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: